Profitable companies and non-Profitable Biotech companies (rising stars) have developed innovative drugs for treatment of chronic and non chronic diseases. In the next five years the distinction between mature biotech companies and large global pharma is likely to disappear as investment in R&D and acquisition start delivering and Market Cap match the large global pharma. Dividend and consolidation could be the future drivers and continue to attract long term investors. Optimism prevails around the future of this sector as a whole which was reflected in the unprecedented rally in shares in 2012.
This trend continued in the next five years driven by launch of Innovative drugs catering to unmet needs in Alzheimer’s, HCV, osteoporosis, RA, Psoriasis, MS, Dyslipidemia, Cystic fibrosis, Cancer and orphan diseases. Drug approvals and label expansion of existing portfolio of launched drugs and data from late stage pipeline drugs should maintain the growth momentum and investors interest.
The early part of the previous decade (2010-20) was spent recovering from the big acquisitions made by this sector but followed by the exercising of some restrain for similar large acquisitions as investors wanted to see the returns reflected in the top-line and EPS. However in- licensing of early or mid stage compounds or small acquisitions continued since the Rising Stars kept throwing the bait by taking risks and innovate using novel technology platforms or validating novel targets for treating diseases.
Patent expiry impact was also modest as majority had “not so easy to copy” biologics and other drugs in their portfolio. They, however were not complacent and were not leaving any stones unturned to meet the challenges as well as exploring emerging market opportunities with local partners. Favorable regulatory environment finally saw biosimilar mAbs entry in regulated markets The optimism of biosimilar players is reflected in the maturing pipeline. Para IV Filing from other generic players continues to pour leaving room for surprises and volatility.
Moving forward the sector should see a strategic rise of the digital mindset and further adoption of transformative and augumentative technologies. While mergers & acquisitions can still expect a sharper focus despite being more traditional, external innovation should result in a meaningful shift in culture through innovative and creative partnerships with both new entrants and less traditional companies.
There will be an increasing demand for even more transparency and disclosure and a need for real relationship-driven partnerships will encroach across all sector stakeholders including regulators, patients, advocacy groups and also to outsourcing players critical to the supply chain. Data will be a dominating force behind new revenue models and crucial to understanding and delivering an exceptional patient experience. Pricing will continue to exert much pressure, increasing access to drugs, growth of gene and cell therapies, and uncertain trade policies will further change the dynamics of the market.
Industry News
- School Restrictions Insufficient to Mitigate Adverse Effects of Mobile Phones and Social Mediaby Bioengineer on February 5, 2025 at 6:49 am
In recent times, the debate surrounding smartphone usage among adolescents in educational settings has intensified, leading to a multitude of policies aimed at regulating their use. A groundbreaking study published in Lancet Regional Health Europe sheds light on the impact of such policies, offering an evidence-based perspective on this pressing issue. This comprehensive research encompassed
- Revitalizing Silicon Electronics: The Emergence of ‘Living’ Electrodesby Bioengineer on February 5, 2025 at 5:41 am
In the pursuit of developing high-speed electronic devices that consume minimal energy, researchers at Osaka University are pushing the boundaries of innovation. The existing trend in electronics has often relied on decreasing the size of devices to enhance their performance. However, this approach has increasingly led to fabrication difficulties, raising questions about the feasibility of
- Delayed Menopause Associated with Improved Vascular Health and Reduced Heart Disease Riskby Bioengineer on February 5, 2025 at 3:22 am
Recent research conducted by the University of Colorado Boulder has uncovered significant insights into women’s cardiovascular health in relation to the timing of menopause. The study, published in the esteemed journal Circulation Research, indicates that women who experience menopause later in life—typically at the age of 55 or older—exhibit healthier blood vessel function long after
- Potential Link Between ‘Good’ Cholesterol and Increased Glaucoma Risk in Individuals Over 55by Bioengineer on February 5, 2025 at 1:15 am
Cholesterol has long been categorized into two types: high-density lipoprotein (HDL), often referred to as “good” cholesterol, and low-density lipoprotein (LDL), typically identified as “bad” cholesterol. This classification has shaped medical advice related to cardiovascular health and, more recently, eye health. However, emerging research suggests that this dichotomy may not be as straightforward as previously
- Groundbreaking Study Unveils the Mechanism of RNA Communication Between Cells Influencing Gene Regulation Across Generationsby Bioengineer on February 5, 2025 at 1:06 am
RNA-based therapeutics represent a revolutionary approach in the quest to combat various human diseases, leveraging the intrinsic targeting abilities of RNA molecules to silence disease-related genes. Recent advancements, particularly in the development of RNA vaccines, have paved the way for innovative treatment strategies. However, a significant challenge persists: how to effectively deliver double-stranded RNA (dsRNA)
- Study Reveals: Morning Perspective Significantly Boosts Optimismby Bioengineer on February 5, 2025 at 1:03 am
The nature of mental health and wellbeing can often feel elusive, fluctuating in response to various external and internal factors. Emerging research highlights a compelling pattern that aligns these states of being closely with the time of day. Findings from a comprehensive study published in BMJ Mental Health have revealed that our mental health experiences
- Study Reveals How Land Use Influences Forest Landowners’ Motivation to Combat Invasive Speciesby Bioengineer on February 4, 2025 at 11:51 pm
The intricacies of forest management in the United States often reveal tensions between individual land ownership and communal environmental responsibilities. With millions of acres of forested land privately owned, particularly in regions like the Eastern and North Central U.S., the delicate balance of invasive Tags: communal environmental responsibilitiesEastern and North Central U.S. forestsecological impacts of
- New Study Reveals Potential Health Risks of Juicing in Just Three Daysby Bioengineer on February 4, 2025 at 11:49 pm
Recent research published by Northwestern University has provided groundbreaking insights into the impacts of juicing on human health, revealing that juice-only diets could lead to adverse effects rather than the anticipated health benefits. The study, which involved healthy adults, examined how various dietary patterns—specifically juice-only diets—affect the microbiome, particularly the gut and oral bacterial compositions.
- USC Secures $10.8 Million Grant for Clinical Trial Aiming to Enhance Hip Fracture Recoveryby Bioengineer on February 4, 2025 at 10:55 pm
The University of Southern California (USC) has recently been granted a significant research funding allocation of $10.8 million from the Patient-Centered Outcomes Research Institute (PCORI). This funding is dedicated to an ambitious clinical trial designed to evaluate different surgical approaches for older adults suffering from hip fractures, specifically femoral neck fractures. The trial, dubbed the
- Coal Emissions Inflict Millions in Crop Damages Across Indiaby Bioengineer on February 4, 2025 at 10:38 pm
In a recently published study by researchers at Stanford University’s Doerr School of Sustainability, alarming insights have emerged regarding the adverse effects of air pollution on crucial agricultural yields in India. The study reveals that emissions from coal-fired power stations are significantly harming wheat and rice production, two staples that are vital for food security
- University Hospitals Cleveland Medical Center Ranks Among Top Academic Medical Institutionsby Bioengineer on February 4, 2025 at 10:37 pm
University Hospitals Cleveland Medical Center (UHCMC) has recently affirmed its prestigious status as a leading institution in healthcare, recognized for its brand strength in the global medical field. In an annual survey conducted by Brand Finance, UHCMC ranked eighth in the U.S. and 16th worldwide among Academic Medical Centers. This accolade sheds light on its
- New Insights: Outside-In Signaling Pathway Linked to Cancer Cell Entryby Bioengineer on February 4, 2025 at 9:36 pm
A groundbreaking new study has emerged that details the intricate mechanism through which an anticancer drug is ushered into cancer cells via an innovative signaling pathway. The research, published in January 2025 in the esteemed journal Nature Communications, unveils significant insights that could potentially transform drug delivery systems in oncology. This work illuminates how monoclonal
- NFL Spouses Introduce Unique Safe Swimming Initiative in New Orleansby Bioengineer on February 4, 2025 at 9:31 pm
The American Heart Association is making waves in the arena of public health, particularly focusing on water safety, highlighted by a recent collaborative initiative that seeks to address one of the most preventable tragedies: drowning. On February 4, 2025, nearly 200 children gathered at Tulane University’s Reily Center, participating in a safe swim event that
- Closing the Divide in Carbon Removal Approaches: New Strategies Unveiledby Bioengineer on February 4, 2025 at 9:29 pm
Biochar, a substance made from biomass that has been processed through pyrolysis, shows great promise in the context of carbon dioxide removal strategies. This charcoal-like material boasts the ability to sequester carbon in the soil over extended periods. However, its potential as a climate change solution may be undermined by the current methods of assessing
- Analyzing biosimilar switching studies: Methodologies and outcomesby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 4, 2025 at 3:42 pm
The Truth About Biosimilar Switching: Separating Fact from Fiction As a healthcare professional, you're likely no stranger to the concept of biosimilars. These highly similar versions of complex biologic medications have been gaining traction in recent... Source
- The Potential of Biosimilars in Pediatric Care: Enhancing Accessibility and Affordabilityby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 3, 2025 at 11:58 am
The Future of Pediatric Care: How Biosimilars Can Make a Real Difference As healthcare professionals, we're constantly looking for ways to improve patient outcomes and make high-quality care more accessible and affordable. One area that holds a lot of ... Source
- The Potential of Biosimilars in Pediatric Care: Enhancing Accessibility and Affordabilityby Insights: DrugPatentWatch - Find Your Next Blockbuster on February 3, 2025 at 11:58 am
Breaking Down Barriers in Pediatric Care: The Power of Biosimilars As healthcare professionals, we're constantly on the lookout for innovative solutions that can improve patient outcomes and make a meaningful difference in their lives. One area that's ... Source
- DrugChatter: How long does lipitor induced muscle pain last?by DrugChatter on January 31, 2025 at 8:08 pm
How Long Does Lipitor-Induced Muscle Pain Last? Understanding Lipitor and Muscle Pain Lipitor, also known as atorvastatin,... https://www.Drugchatter.com/chat/9317/how-long-does-lipitor-induced-muscle-pain-last/ Source
- Marketing Your Patented Drug Effectively: Strategies for Maximizing Patent Protection and Exclusivityby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 30, 2025 at 2:39 pm
Maximizing Patent Protection: The Key to Unlocking Your Pharmaceutical's Full Potential As a pharmaceutical professional, you know how crucial it is to protect your patented drug from generic competition. But did you know that effective marketing can p... Source
- Breaking Down the Cost of Generic Drug Production: Understanding the Factors Influencing Affordabilityby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 29, 2025 at 9:48 am
The Hidden Costs Behind Your Generic Medications: What's Driving the Price? As we navigate the complex world of healthcare, it's easy to overlook the intricacies of generic drug production. But have you ever wondered what factors contribute to the affo... Source
- Patent Term Extension Calculator: Step-by-Step Expert Guideby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 28, 2025 at 1:51 pm
Maximize Your Patent Protection: A Step-by-Step Guide to Patent Term Extension As a pharmaceutical professional, you know how crucial it is to protect your intellectual property and extend the life of your patent. Patent term extension (PTE) can be a g... Source
- DrugChatter: Have you experienced any lipitor withdrawal symptoms?by DrugChatter on January 28, 2025 at 12:45 am
Lipitor Withdrawal Symptoms: What You Need to Know As one of the most widely prescribed cholesterol-lowering medications,... https://www.Drugchatter.com/chat/31342/have-you-experienced-any-lipitor-withdrawal-symptoms/ Source
- How to Ensure CDMO Transparencyby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 27, 2025 at 12:18 pm
The Secret to Building Trust with Your CDMO: Unlocking Transparency As a pharmaceutical professional, you know that partnering with a Contract Development and Manufacturing Organization (CDMO) is a crucial step in bringing your life-changing products t... Source
- Avadel CNS Pharmaceuticals, LLC v. Jazz Pharmaceuticals, Inc.by Insights: DrugPatentWatch - Find Your Next Blockbuster on January 26, 2025 at 3:43 pm
The Battle for CNS Medications: What's at Stake for Pharmaceutical Companies? As we navigate the complex world of pharmaceuticals, it's essential to stay informed about the latest developments that can impact the industry. Recently, a significant case ... Source
- Astellas Pharma Inc. v. Creekwood Pharmaceuticals LLCby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 26, 2025 at 3:41 pm
The Battle for Generic Medication: Astellas Pharma Inc. v. Creekwood Pharmaceuticals LLC As we navigate the complex world of pharmaceuticals, it's essential to stay informed about the latest developments in patent law. A recent case, Astellas Pharma In... Source
- Taizhou Luqiao Shengqiang Housewares Factory v. Dbest Products Inc.by Insights: DrugPatentWatch - Find Your Next Blockbuster on January 26, 2025 at 3:33 pm
Patent Disputes in the Global Market: A Cautionary Tale As a business leader, you're likely no stranger to the complexities of intellectual property law. But have you ever found yourself at the center of a patent dispute? It's a situation that can be b... Source
- Nexus Pharmaceuticals, LLC v. Hikma Pharmaceuticals USA Inc.by Insights: DrugPatentWatch - Find Your Next Blockbuster on January 26, 2025 at 3:03 pm
The Battle for Generic Medication Access: A Landmark Patent Case As we navigate the complex world of pharmaceuticals, it's essential to understand the intricacies of patent law and its impact on patients. Recently, the case of Nexus Pharmaceuticals LLC... Source
- Pfizer Inc. v. Alkem Laboratories Limitedby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 26, 2025 at 2:54 pm
The Battle for Generic Medications: A Look at Pfizer Inc. v. Alkem Laboratories Limited As we navigate the complex world of pharmaceuticals, it's essential to understand the intricacies of patent law and its impact on the availability of generic medica... Source
- Strategies for effective biosimilar clinical trial design and executionby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 23, 2025 at 11:15 am
Unlocking the Potential of Biosimilars: Strategies for Success in Clinical Trial Design and Execution As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the fight against high healthcare costs. By leveragi... Source
- The Future of Generic Drug Development for Emerging Markets: Opportunities and Challengesby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 23, 2025 at 8:56 am
The Future of Generic Drug Development: Opportunities and Challenges for Emerging Markets As the global healthcare landscape continues to evolve, emerging markets are playing an increasingly important role in shaping the future of generic drug developm... Source
- The Science Behind Generic Drug Bioequivalenceby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 22, 2025 at 11:00 pm
The Unseen Heroes of the Pharmaceutical Industry: Understanding Bioequivalence As we navigate the complex world of pharmaceuticals, it's easy to overlook the unsung heroes that make generic drugs possible. Today, I want to shine a light on the science ... Source
- The Role of Good Manufacturing Practice (GMP) in Generic Drug Manufacturing: Ensuring Quality and Safetyby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 22, 2025 at 9:09 am
The Unseen Heroes of Generic Drug Manufacturing: Good Manufacturing Practice (GMP) As we navigate the complex world of pharmaceuticals, it's easy to overlook the behind-the-scenes efforts that ensure the quality and safety of the medicines we rely on. ... Source
- The Regulatory Pathway for Generic Drugs Explainedby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 22, 2025 at 8:52 am
The Path to Generic Medication: A Journey Through Regulatory Hurdles As a healthcare professional or a business leader in the pharmaceutical industry, you're likely no stranger to the complex world of generic medications. But have you ever wondered wha... Source
- Best Practices for Drug Patent Portfolio Managementby Insights: DrugPatentWatch - Find Your Next Blockbuster on January 21, 2025 at 11:24 pm
Maximizing the Value of Your Pharmaceutical Portfolio: Expert Insights on Best Practices for Drug Patent Portfolio Management As a pharmaceutical professional, you know that a well-managed patent portfolio is crucial for protecting your company's innov... Source